Dofetilide Initiation and Implications of Deviation From the Standard Protocol – A Real World Experience

BACKGROUND: Manufacturer/federal drug administration (FDA) recommends inpatient initiation of dofetilide with the manufacturer providing an initiation algorithm. The outcomes of algorithm deviation have not been reported outside of clinical trials. OBJECTIVE: We sought to perform a chart review of a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Atr Fibrillation
Main Authors: Dar, Tawseef, Murtaza, Ghulam, Yarlagadda, Bharath, Madoukh, Bader, Bravin, Lesley, Vuddanda, Venkat, Parikh, Valay, Reddy, Madhu, Lakkireddy, Dhanunjaya
Formato: Artigo
Idioma:Inglês
Publicado em: Cardiofront, Inc 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7237080/
https://ncbi.nlm.nih.gov/pubmed/32435348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.2265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados